Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Cutaneous Melanoma”

171 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 171 results

Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Not applicableStudy completedNCT01183936
What this trial is testing

Trial of Surgical Excision Margins in Thick Primary Melanoma

Who this might be right for
MelanomaSurgeryTreatment Outcome
Karolinska Institutet 936
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Large-scale testing (Phase 3)Ended earlyNCT00036816
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 13
Not applicableLooking for participantsNCT05108298
What this trial is testing

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Who this might be right for
Breast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more
Eastern Cooperative Oncology Group 400
Not applicableStudy completedNCT01016899
What this trial is testing

Electronic Brachytherapy for the Treatment of NMSC

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma
Xoft, Inc. 187
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Not applicableEnded earlyNCT05266430
What this trial is testing

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

Who this might be right for
Choroidal MelanomaIndeterminate Lesions
Aura Biosciences 2
Early research (Phase 1)Active Not RecruitingNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT02966509
What this trial is testing

Engagement of Patients With Advanced Cancer

Who this might be right for
End of LifeAdvanced CancerLung Neoplasm+11 more
Stanford University 213
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT06221397
What this trial is testing

Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma

Who this might be right for
MelanomaMelanoma, Skin
AI Labs Group S.L 200
Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Large-scale testing (Phase 3)UnknownNCT00002763
What this trial is testing

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Not applicableNot Yet RecruitingNCT07349940
What this trial is testing

Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care

Who this might be right for
Skin Cancer PreventionMelanoma In SituSkin Lesions+2 more
Institute of Health Information and Statistics of the Czech Republic 1,440
Early research (Phase 1)Ended earlyNCT04543188
What this trial is testing

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Who this might be right for
Malignant MelanomaCarcinoma, Non-Small-Cell LungBrain Neoplasms, Primary+2 more
Pfizer 65
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Load More Results